PL2281204T3 - Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów - Google Patents

Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów

Info

Publication number
PL2281204T3
PL2281204T3 PL09739657T PL09739657T PL2281204T3 PL 2281204 T3 PL2281204 T3 PL 2281204T3 PL 09739657 T PL09739657 T PL 09739657T PL 09739657 T PL09739657 T PL 09739657T PL 2281204 T3 PL2281204 T3 PL 2281204T3
Authority
PL
Poland
Prior art keywords
abuse
metabolites
drugs
solid phase
phase multi
Prior art date
Application number
PL09739657T
Other languages
English (en)
Inventor
Virginia Hill
Mohammad Atefi
Michael I Schaffer
Original Assignee
Psychemedics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psychemedics Corp filed Critical Psychemedics Corp
Publication of PL2281204T3 publication Critical patent/PL2281204T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Sampling And Sample Adjustment (AREA)
PL09739657T 2008-04-29 2009-04-29 Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów PL2281204T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4889208P 2008-04-29 2008-04-29
PCT/US2009/042061 WO2009134855A1 (en) 2008-04-29 2009-04-29 Solid phase multi-analyte assay
EP09739657.6A EP2281204B1 (en) 2008-04-29 2009-04-29 Solid phase multi-analyte assay for drugs of abuse and their metabolites

Publications (1)

Publication Number Publication Date
PL2281204T3 true PL2281204T3 (pl) 2014-06-30

Family

ID=40802062

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09739657T PL2281204T3 (pl) 2008-04-29 2009-04-29 Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów
PL13162193T PL2623987T3 (pl) 2008-04-29 2009-04-29 Analiza wieloanalitowa w fazie stałej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13162193T PL2623987T3 (pl) 2008-04-29 2009-04-29 Analiza wieloanalitowa w fazie stałej

Country Status (10)

Country Link
US (1) US10539580B2 (pl)
EP (2) EP2281204B1 (pl)
JP (2) JP5564491B2 (pl)
CN (2) CN105675892A (pl)
BR (1) BRPI0911552B8 (pl)
CA (2) CA2723162C (pl)
ES (2) ES2452473T3 (pl)
HU (1) HUE028235T2 (pl)
PL (2) PL2281204T3 (pl)
WO (1) WO2009134855A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2281204T3 (pl) 2008-04-29 2014-06-30 Psychemedics Corp Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów
CN102323414B (zh) * 2011-06-07 2013-09-11 西安金域医学检验所有限公司 一种苯巴比妥均相酶免疫检测试剂盒及其制备方法
US20140004534A1 (en) 2012-06-28 2014-01-02 Psychemedics Corporation Detection of analytes in hair wash samples
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
IL314752A (en) 2016-09-16 2024-10-01 Takeda Pharmaceuticals Co Metabolite biomarkers for diseases associated with the contact activation system
AU2017336002B2 (en) 2016-09-30 2022-09-08 Gen-Probe Incorporated Compositions on plasma-treated surfaces

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US832917A (en) * 1906-02-26 1906-10-09 George A Macbeth Colored signal-lens.
US5324642A (en) 1987-12-28 1994-06-28 Psychemedics Corporation Ligand assays of enzymatic hair digests
US5466579A (en) 1987-12-28 1995-11-14 Psychemedics Corporation Hair analysis method
US6022693A (en) 1987-12-28 2000-02-08 Psychemedics Corporation Hair analysis method
US6582924B1 (en) 1987-12-28 2003-06-24 Psychemedics Corporation Hair analysis method
US6949344B1 (en) 1987-12-28 2005-09-27 Psychemical Corporation Hair analysis method
US4956467A (en) 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JPH01276066A (ja) * 1988-04-28 1989-11-06 Mitsui Petrochem Ind Ltd 免疫検定法による低分子化合物の検出方法
JP2837921B2 (ja) 1990-05-22 1998-12-16 サイケメディクス コーポレイション 毛髪分析法
DE69119312T2 (de) 1990-07-18 1997-01-16 Abbott Lab Analyt-Austauschreagenz zur Verwendung in spezifischen Bindungstests, -vorrichtungen und -sätzen
US5712157A (en) 1994-12-20 1998-01-27 University Of Washington Methods and materials for the immunoassay of apolipoprotein(a) and lipoprotein(a)
DE19504198A1 (de) 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
US6231982B1 (en) 1997-12-10 2001-05-15 Dade Behring Inc. Particle reagents having reduced matrix effects and containing an aldehyde-reactive functional group
AU2679899A (en) 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
JPH11248703A (ja) * 1998-03-04 1999-09-17 Sanyo Chem Ind Ltd 遊離ハプテンの免疫学的測定法
GB2339615B (en) * 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
US7297554B2 (en) 1998-11-18 2007-11-20 Microdiagnostics, Inc. Immunoassay system
JP4288750B2 (ja) * 1999-05-14 2009-07-01 日油株式会社 免疫学的測定方法
US6509196B1 (en) * 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
WO2001084157A2 (en) 2000-05-04 2001-11-08 Dade Behring Marburg Gmbh Compositions for detection of multiple analytes
US7083925B2 (en) 2002-01-11 2006-08-01 Schnabel Robert D Method of parentage testing in North American bison, Bison bison and domestic cattle using microsatellite loci
US7399470B2 (en) * 2002-03-12 2008-07-15 Japan Science And Technology Agency Sandwich immunoassay kits for detecting ciguatoxin CTX3C
US7067258B2 (en) * 2002-04-30 2006-06-27 Merck & Co., Inc. Human papillomavirus multiplexed assay
US7195875B2 (en) 2003-04-18 2007-03-27 Beckman Coulter, Inc. Oligonucleotide pairs for multiplexed binding assays
US20040241776A1 (en) 2003-05-22 2004-12-02 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
US7413868B2 (en) * 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
CN1673745A (zh) 2003-12-20 2005-09-28 苏冬梅 酶联免疫吸附elisa同步快速测定多项免疫指标的方法
US7618591B2 (en) 2004-01-28 2009-11-17 Bamburgh Marrsh Llc Specimen sample collection device and test system
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
US20060166376A1 (en) 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7629129B1 (en) 2005-04-26 2009-12-08 The United States Of America As Represented By The Secretary Of The Army Hair follicle bulb as a biodosimeter
CA2607284A1 (en) * 2005-05-11 2006-11-23 Embrex, Inc. Competitive particle immunoassay methods utilizing fluorescence microscopy
US7795040B2 (en) * 2006-04-17 2010-09-14 Luminex Corporation Methods, particles, and kits for determining activity of a kinase
CN1885038B (zh) 2006-07-11 2010-08-18 华南农业大学 一种检测克伦特罗酶联免疫试剂盒及其检测方法与检测前动物组织的制样方法
EP2069790B1 (en) * 2006-11-01 2015-04-29 Beckman Coulter, Inc. Binding surfaces for affinity assays
PL2281204T3 (pl) 2008-04-29 2014-06-30 Psychemedics Corp Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów
US8084215B2 (en) 2008-04-29 2011-12-27 Psychemedics Corporation Non-proteolytic method for the determination of analytes in keratinized structures

Also Published As

Publication number Publication date
JP2014209123A (ja) 2014-11-06
ES2452473T3 (es) 2014-04-01
PL2623987T3 (pl) 2016-07-29
CN102077094B (zh) 2016-03-09
CN102077094A (zh) 2011-05-25
ES2562659T3 (es) 2016-03-07
BRPI0911552A2 (pt) 2019-03-06
JP5564491B2 (ja) 2014-07-30
US20110118138A1 (en) 2011-05-19
BRPI0911552B1 (pt) 2019-11-05
US10539580B2 (en) 2020-01-21
WO2009134855A1 (en) 2009-11-05
CA2723162A1 (en) 2009-11-05
JP5890864B2 (ja) 2016-03-22
EP2281204A1 (en) 2011-02-09
JP2011519048A (ja) 2011-06-30
CA2943923C (en) 2018-02-06
HK1154072A1 (en) 2012-04-13
EP2623987B1 (en) 2015-12-30
CA2723162C (en) 2016-11-01
CA2943923A1 (en) 2009-11-05
HUE028235T2 (en) 2016-12-28
BRPI0911552B8 (pt) 2021-07-27
EP2281204B1 (en) 2014-01-08
HK1155221A1 (zh) 2012-05-11
EP2623987A1 (en) 2013-08-07
HK1186522A1 (en) 2014-03-14
CN105675892A (zh) 2016-06-15

Similar Documents

Publication Publication Date Title
HUS2000028I1 (hu) VEGF-gátló, stabilis és oldható antitestek
EP3184546B8 (en) Human cgrp receptor binding antibodies
IL240268A0 (en) Technology for the preparation of macromolecular microspheres
PT2246427T (pt) Anticorpos capazes de se ligar especificamente a oligómeros beta amilóides e a sua utilização
BRPI0909750A2 (pt) dispositivo e cápsula para a preparação de uma bebida
IL210762A0 (en) Repositionable endoluminal support structure and its applications
PL2370045T3 (pl) Wkład, dozownik leku do porcji leku w fazie stałej oraz zastosowania wkładu i dozownika leku
IL207276A0 (en) Benzodiazepine compound and pharmaceutical composition
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
PL2281204T3 (pl) Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów
AP3000A (en) Slow release pharmaceutical composition made of microparticles
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
GB0605427D0 (en) Materials For Binding Drugs Of Abuse
GB0802873D0 (en) Pharmaceutical dosage forms for delayed and extended release
TWI347933B (en) Derivatives of binol and application thereof
AU2007906867A0 (en) Non-distribution of data structures
HK1158217A (en) Anti-tgf-beta receptor ii antibodies
TH0901005279A (th) คาร์ทริดจ์, ตัวจ่ายยาสำหรับส่วนของยาที่เป็นของแข็ง, และการใช้ของคาร์ทริดจ์และของตัวจ่ายยา